HK1243341A1 - 起泡減少的疫苗組合物 - Google Patents

起泡減少的疫苗組合物

Info

Publication number: HK1243341A1
Authority: HK; Hong Kong
Prior art keywords: vaccine compositions; reduced foaming; foaming; reduced; vaccine
Prior art date: 2014-10-10

Application number

HK18102910.3A

Other languages

English (en)

Inventor

Yves Henri Jean Genin Noel

Original Assignee

Merial Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-10-10

Filing date

2018-02-28

Publication date

2018-07-13

2018-02-28 Application filed by Merial Inc filed Critical Merial Inc

2018-07-13 Publication of HK1243341A1 publication Critical patent/HK1243341A1/zh

Links

238000005187 foaming Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Pulmonology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Inorganic Chemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Biotechnology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

HK18102910.3A 2014-10-10 2018-02-28 起泡減少的疫苗組合物 HK1243341A1 (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201462062180P	2014-10-10	2014-10-10
PCT/US2015/055027 WO2016057978A1 (en)	2014-10-10	2015-10-09	Reduced foaming vaccine compositions

Publications (1)

Publication Number	Publication Date
HK1243341A1 true HK1243341A1 (zh)	2018-07-13

Family

ID=55653887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK18102910.3A HK1243341A1 (zh)	2014-10-10	2018-02-28	起泡減少的疫苗組合物

Country Status (21)

Country	Link
US (6)	US10188734B2 (zh)
EP (1)	EP3203988B1 (zh)
JP (2)	JP2017534609A (zh)
KR (1)	KR102652509B1 (zh)
CN (1)	CN107106667B (zh)
AR (1)	AR102250A1 (zh)
AU (2)	AU2015330716B2 (zh)
BR (1)	BR112017007422A8 (zh)
CA (1)	CA2964171C (zh)
CO (1)	CO2017004271A2 (zh)
ES (1)	ES2895494T3 (zh)
HK (1)	HK1243341A1 (zh)
MX (1)	MX2017004679A (zh)
MY (1)	MY198730A (zh)
NZ (1)	NZ731296A (zh)
PH (1)	PH12017500661A1 (zh)
PL (1)	PL3203988T3 (zh)
RU (1)	RU2731534C2 (zh)
TW (1)	TWI745278B (zh)
UA (1)	UA126057C2 (zh)
WO (1)	WO2016057978A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112019010830A2 (pt)	2016-11-30	2019-10-01	Boehringer Ingelheim Animal Health Usa Inc	vacinas atenuadas de influenza suína e métodos de produção e uso das mesmas
CN110308145A (zh) *	2019-07-10	2019-10-08	迪瑞医疗科技股份有限公司	一种沙眼衣原体糖原检测试剂、沙眼衣原体糖原检测试纸条及其制备方法
BR112023005001A2 (pt) *	2020-09-22	2023-04-18	Univ Georgia	Isolado atenuado do vírus da estirpe dmv1639 de bronquite infecciosa

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3184384A (en) *	1961-09-07	1965-05-18	Dow Chemical Co	Method of producing brucella abortus vaccine
IL46189A (en)	1974-12-05	1979-01-31	Vineland Lab Ltd	Color coded poultry vaccines
JPS60193925A (ja) *	1984-03-13	1985-10-02	Chemo Sero Therapeut Res Inst	凍結乾燥製剤化ワクチン
US5178862A (en)	1989-12-01	1993-01-12	Parhelion Corporation	Canine distemper virus vaccine and method of preparation
FR2662942B1 (fr)	1990-06-06	1992-09-18	Neway Tsehay	Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
US5846805A (en)	1991-08-26	1998-12-08	Boehringer Ingelheim Animal Health, Inc.	Culture of swine infertility and respiratory syndrome virus in simian cells
US5338543A (en)	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5695766A (en)	1992-10-30	1997-12-09	Iowa State University Research Foundation	Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
KR100374295B1 (ko)	1993-02-08	2003-12-24	바이엘 코포레이션	돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도
US5595761A (en)	1994-01-27	1997-01-21	The Board Of Regents Of The University Of Oklahoma	Particulate support matrix for making a rapidly dissolving tablet
FR2723740B1 (fr)	1994-08-16	1996-11-08	Pasteur Merieux Serums Vacc	Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US5866401A (en)	1996-03-01	1999-02-02	Schering Corporation	Porcine reproductive and respiratory syndrome vaccine
US6391314B1 (en)	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
GB9722682D0 (en)	1997-10-27	1997-12-24	Scherer Ltd R P	Pharmaceutical products
US6592869B2 (en)	1999-08-24	2003-07-15	Teva Pharmaceutical Industries, Ltd.	Vaccine composition and method of using the same
CA2382652A1 (en)	1999-08-24	2001-03-01	Teva Pharmaceutical Industries, Ltd.	A vaccine composition and method of using the same
CN1233418C (zh) *	2001-12-21	2005-12-28	卫广森	鸡传染性支气管炎h120或h52与鸡新城疫二联冻干疫苗耐热冻干保护剂及制备工艺
CN100381463C (zh) *	2002-09-18	2008-04-16	中国人民解放军免疫学研究所	用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途
AU2002951692A0 (en)	2002-09-23	2002-10-17	Vital Biotech (Hong Kong) Limited	Improvements in or relating to vaccines
CN1284601C (zh) *	2003-05-22	2006-11-15	维奥（四川）生物技术有限公司	常温稳定的疫苗组合物及其制备方法
CN1261161C (zh) *	2003-11-10	2006-06-28	钱汶光	复方干扰素诱生剂***片
ES2390354T3 (es)	2005-07-22	2012-11-12	Amgen, Inc	Liofilizados de proteínas concentrados, procedimientos y usos
WO2007132480A2 (en) *	2006-05-12	2007-11-22	Bharat Biotech International Limited	A composition useful as a vaccine
UA46896U (ru) *	2009-07-13	2010-01-11	Владимир Николаевич Дзюба	Способ изготовления вакцины живой споровой концентрированной против сибирской язвы животных
CN103347494A (zh) *	2010-10-08	2013-10-09	R·P·舍勒科技有限责任公司	使用淀粉的口服疫苗快速溶解剂型
CN102160856A (zh) *	2011-03-28	2011-08-24	南京易海生物科技有限公司	鸡传染性法氏囊病防漏型饮水免疫片及其制备方法
AR097762A1 (es)	2013-09-27	2016-04-13	Intervet Int Bv	Formulaciones secas de vacunas que son estables a temperatura ambiente

2015
- 2015-10-08 TW TW104133291A patent/TWI745278B/zh active
- 2015-10-09 WO PCT/US2015/055027 patent/WO2016057978A1/en active Application Filing
- 2015-10-09 NZ NZ731296A patent/NZ731296A/en unknown
- 2015-10-09 MY MYPI2017000526A patent/MY198730A/en unknown
- 2015-10-09 CN CN201580061142.1A patent/CN107106667B/zh active Active
- 2015-10-09 MX MX2017004679A patent/MX2017004679A/es unknown
- 2015-10-09 JP JP2017519291A patent/JP2017534609A/ja active Pending
- 2015-10-09 KR KR1020177011822A patent/KR102652509B1/ko active IP Right Grant
- 2015-10-09 RU RU2017115776A patent/RU2731534C2/ru active
- 2015-10-09 PL PL15801958T patent/PL3203988T3/pl unknown
- 2015-10-09 ES ES15801958T patent/ES2895494T3/es active Active
- 2015-10-09 BR BR112017007422A patent/BR112017007422A8/pt active Search and Examination
- 2015-10-09 EP EP15801958.8A patent/EP3203988B1/en active Active
- 2015-10-09 US US14/880,145 patent/US10188734B2/en active Active
- 2015-10-09 CA CA2964171A patent/CA2964171C/en active Active
- 2015-10-09 AU AU2015330716A patent/AU2015330716B2/en active Active
- 2015-10-09 UA UAA201704437A patent/UA126057C2/uk unknown
- 2015-10-13 AR ARP150103298A patent/AR102250A1/es active IP Right Grant
2017
- 2017-04-07 PH PH12017500661A patent/PH12017500661A1/en unknown
- 2017-04-27 CO CONC2017/0004271A patent/CO2017004271A2/es unknown
2018
- 2018-02-28 HK HK18102910.3A patent/HK1243341A1/zh unknown
- 2018-09-10 US US16/125,911 patent/US10213509B2/en active Active
- 2018-11-30 AU AU2018271395A patent/AU2018271395B2/en active Active
2019
- 2019-01-24 US US16/256,463 patent/US10610596B2/en active Active
2020
- 2020-02-26 US US16/802,089 patent/US20200188519A1/en not_active Abandoned
- 2020-09-11 JP JP2020152793A patent/JP2021004246A/ja active Pending
2022
- 2022-01-21 US US17/580,896 patent/US20220241421A1/en not_active Abandoned
2023
- 2023-10-09 US US18/483,149 patent/US20240042037A1/en active Pending

Also Published As

Publication number	Publication date
EP3203988B1 (en)	2021-09-01
US20200188519A1 (en)	2020-06-18
EP3203988A1 (en)	2017-08-16
MX2017004679A (es)	2017-08-08
US20190151451A1 (en)	2019-05-23
PL3203988T3 (pl)	2022-02-14
US10610596B2 (en)	2020-04-07
US10213509B2 (en)	2019-02-26
CO2017004271A2 (es)	2017-09-29
BR112017007422A2 (pt)	2018-01-16
JP2021004246A (ja)	2021-01-14
US20240042037A1 (en)	2024-02-08
WO2016057978A1 (en)	2016-04-14
AU2015330716A1 (en)	2017-05-18
US20220241421A1 (en)	2022-08-04
AU2015330716B2 (en)	2018-12-06
CA2964171A1 (en)	2016-04-14
CN107106667A (zh)	2017-08-29
TW201625296A (zh)	2016-07-16
KR102652509B1 (ko)	2024-03-28
AR102250A1 (es)	2017-02-15
US20160256554A1 (en)	2016-09-08
CA2964171C (en)	2023-03-28
JP2017534609A (ja)	2017-11-24
UA126057C2 (uk)	2022-08-10
MY198730A (en)	2023-09-20
AU2018271395B2 (en)	2020-05-14
AU2018271395A1 (en)	2018-12-20
BR112017007422A8 (pt)	2022-07-12
KR20170066532A (ko)	2017-06-14
PH12017500661A1 (en)	2017-10-09
RU2017115776A3 (zh)	2019-04-11
TWI745278B (zh)	2021-11-11
US10188734B2 (en)	2019-01-29
NZ731296A (en)	2018-08-31
RU2731534C2 (ru)	2020-09-04
ES2895494T3 (es)	2022-02-21
RU2017115776A (ru)	2018-11-12
CN107106667B (zh)	2022-03-15
US20190000978A1 (en)	2019-01-03

Publication	Publication Date	Title
ZA201801035B (en)	2019-01-30	Vaccine compositions
GB201410971D0 (en)	2014-08-06	Vaccine
GB201407934D0 (en)	2014-06-18	Formulation
IL248223A0 (en)	2016-11-30	Compositions of vaccine
EP3154929A4 (en)	2018-06-13	Foam compositions
GB201419261D0 (en)	2014-12-10	Formulations
GB201419091D0 (en)	2014-12-10	Formulations
IL251479B (en)	2020-11-30	components
GB201408167D0 (en)	2014-06-25	Compositions
HK1243341A1 (zh)	2018-07-13	起泡減少的疫苗組合物
HUE048950T2 (hu)	2020-09-28	Ceritinib formuláció
GB201420306D0 (en)	2014-12-31	Compositions
GB201407384D0 (en)	2014-06-11	Formulation
SI3188755T1 (sl)	2021-03-31	Cepivo
GB201417020D0 (en)	2014-11-12	Formulation
GB201402448D0 (en)	2014-03-26	Novel formulation
GB201511301D0 (en)	2015-08-12	Formulation
GB201417214D0 (en)	2014-11-12	Vaccine
GB201611084D0 (en)	2016-08-10	Vaccine compositions
GB201521608D0 (en)	2016-01-20	Vaccine composition
GB201419849D0 (en)	2014-12-24	Compositions
GB201401883D0 (en)	2014-03-19	Combination immunogenic compositions
GB201406863D0 (en)	2014-05-28	Compositions comprising variegin
GB201411371D0 (en)	2014-08-13	Immunogenic composition
GB201411306D0 (en)	2014-08-06	Immunogenic composition